Biogen, 6.875% 1mar2018, USD (US09062XAB91)

Download

Copy issue information to clipboard

Copy to clipboard

Data copied to the clipboard

PDF download

Choose all Reset all

Download Cancel

International bonds

Status

Early redeemed

Amount

550,000,000 USD

Placement

***

Early redemption

*** (-)

ACI on

Country of risk

USA

Current coupon

Price

Yield / Duration

Calculate in two clicks! yield, duration and other parameters

Calculator What is a calculator?

Placement amount

550,000,000 USD
Minimum Settlement Amount

2,000 USD
ISIN

US09062XAB91
CFI

DBFUGR
FIGI

BBG0000MW647
SEDOL

B2Q4667
Ticker

BIIB 6.875 03/01/18

explore the most comprehensive database

900 000

bonds globally

Over 400

pricing sources

80 000

stocks

116 000

ETF & Funds

track your portfolio in the most efficient way

Bond Search
Watchlist
Excel ADD-IN

Get access

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 900 000 bonds, 80 000 stocks, 116 000 ETF & Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs

Get full access to the platform from any device & via Cbonds app

Enhance your portfolio management with Cbonds Excel Add-in

Build yield maps, make chart comparison within a click

Don't wait any longer — start using Cbonds today! Register

Files

Prospectus

Prospectus Supplement

Authorization required

It is only possible to download bond prospectuses for paid Premium subscription access

Trading chart

Stock exchange selection

More about Cbonds Estimation

Bond is not traded; the issue is redeemed

Data display in a chart | table

Work with the chart: switching the price, period, issue comparison

Customize fields in the table

Found:

Show all fields

from

ADD-IN
Cbonds add-in API
bond data api

Authorization required

You need to request access

* Data is not available within the selected subscription

Issue information

Profile

Biogen Inc. is a global biotechnology company. The Company discovers, develops, manufactures and markets therapies for the treatment of neurodegenerative diseases, hemophilia and autoimmune disorders. The Company’s products include AVONEX, TYSABRI, FAMPYRA, FUMADERM and RITUXAN.

Research report by Cbonds-PRAAMS

Save

Authorization required

Report download is available only paid Premium subscription access

Borrower

Go to the issuer page
Biogen
Full borrower / issuer name

Biogen
Sector

Corporate
Industry

Pharmaceutical Preparation and Biotechnology
Stocks

Biogen, ordinary share
Biogen, Brazilian depositary receipt (GDR)
Biogen, depositary receipt

Volume

Placement amount

550,000,000 USD

Face value

Minimum Settlement Amount

2,000 USD
Outstanding face value

*** USD
Increment

*** USD
Face value

1,000 USD

Listing

Listing

***

Cash flow parameters

Reference rate

***

Coupon Rate

***

Day count convention

***

Interest Accrual Date

***

Coupon frequency

*** time(s) per year
Payment currency

***
Maturity date

***
Early redemption date

***

Cash flow

Calculations for international bonds are made according to the minimum trading lot

Export to Excel

Early redemption terms

***

explore the most comprehensive database

900 000

bonds globally

Over 400

pricing sources

80 000

stocks

116 000

ETF & Funds

track your portfolio in the most efficient way

Bond Search
Watchlist
Excel ADD-IN

Get access

— Are you looking for the complete & verified bond data?

— We have everything you need:

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs

Get full access to the platform from any device & via Cbonds app

Enhance your portfolio management with Cbonds Excel Add-in

Build yield maps, make chart comparison within a click

Don't wait any longer — start using Cbonds today! Register

Placement

Placement method

Open subscription
Placement type

Public
Placement

***
Initial issue price (yield)
Geographic breakdown

***
Investor breakdown

***

Participants

Bookrunner

***, ***

Conversion and exchange

Conversion terms

***

Latest issues

Show all

Similar issues

News

07/05/2025	S&P: Biogen Inc.'s Senior Unsecured Notes Rated 'BBB+' (Rating action commentary)
07/05/2025	New issues: Biogen issued international bonds (US09062XAL73, US09062XAM56) in the amount of USD 650, USD 700 mln maturing in 2035, 2055 respectively.
07/05/2025	New issue: Biogen issued international bonds (US09062XAN30) with the coupon rate of 5.05% in the amount of USD 400 mln maturing in 2031
06/05/2025	Moody's Ratings assigns Baa2 rating to Biogen's notes; stable outlook (Rating action commentary)
06/05/2025	Biogen: Other Events, Financial Statements And Exhibits

All organization news

IFRS/US GAAP reports

2025
	I q eng



2024
	I q eng
	II q eng
	III q eng
	IV q eng
2023
	I q eng
	II q eng
	III q eng
	IV q eng
2022
	I q eng
	II q eng
	III q eng
	IV q eng
2021
	I q eng
	II q eng
	III q eng
	IV q eng
2020
	I q eng
	II q eng
	III q eng
	IV q eng
2019
	I q eng
	II q eng
	III q eng
	IV q eng
2018
	I q eng
	II q eng
	III q eng
	IV q eng
2017
	I q eng
	II q eng
	III q eng
	IV q eng
2016
	I q eng
	II q eng
	III q eng
	IV q eng
2015
	I q eng
	II q eng
	III q eng
	IV q eng
2014



	IV q eng

Show all Hide

Authorization required

You need to request access

Identifiers

ISIN

***
Cbonds ID

53397
CUSIP

***
CUSIP 144A

***
CFI

DBFUGR
FIGI

BBG0000MW647
WKN

A0UK7Q
SEDOL

B2Q4667
Ticker

BIIB 6.875 03/01/18
Type of security by CBR

***

Ratings

Bond classification

Rank: Undefined
Registered
Coupon bonds
Amortization
Callable
CDO
Convertible
Dual currency bonds
Variable rate
For qualified investors (CIS region)
Foreign bonds
Green bonds
Guaranteed
Inflation-linked principal
Supranational bond issues
Inflation-linked coupon
Mortgage bonds
Non-complex financial instruments (MiFID)
Perpetual
Payment-in-kind
Non-Marketable Securities
Redemption Linked
Restructuring
Retail bonds
Covered
Securitization
Structured product
Commercial Bonds
Subordinated
Sukuk
Trace-eligible

Show more Hide

Restructuring

***